Medical Responses To Opioid Addiction Vary By State, Analysis Finds
The study also found that the largest percentage of medical coverage claims related to opioid abuse and dependence nationally come from older patients — those ages 51 to 60.
Health Industry
2,581-2,600 of 4,019 results
-
-
‘How Long Have I Got, Doc?’ Why Many Cancer Patients Don’t Have Answers
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
By Liz Szabo -
Quantity Over Quality? Minorities Shown To Get An Excess Of Ineffective Care
The researchers looked at 11 services that medical groups have said are often unnecessary and found that Hispanics and blacks got them at higher rates than whites.
-
If Insurance Market Crashes, Can Lawmakers Put The Pieces Back Together?
Actions by the Trump administration are putting pressure on the fragile market for individuals who buy their own coverage, but analysts say it should be able to rebound.
By Julie Rovner -
Former Pharma Reps’ New Mission: To School Docs On High Drug Costs
One insurer is turning the tables on drugmakers with what may be a new job category: a sales force for cost-effective medicine.
By Jay Hancock -
Daylight On Diabetes Drugs: Nevada Bill Would Track Insulin Makers’ Profits
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
By Emily Kopp -
When An Insurer Balks And Treatment Stops
A 22-year old man from Orange County, Calif., alleges in a lawsuit that his health insurer stopped paying for a crucial — and expensive — immunotherapy drug, leading him to become seriously ill. Treatments for patients with similar conditions are increasingly denied or interrupted, experts and patient advocates say.
By Anna Gorman -
Hospitals Now Tap Lawyers To Fulfill Patients’ Legal Needs
About 300 health care systems around the country have set up medical-legal partnerships to help patients who are dealing with legal problems that affect their health.
-
As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
By Liz Szabo -
Drug Rebates Reward Industry Players — And Often Hurt Patients
A new JAMA study examines how drug rebates can direct money to middlemen and force Medicare patients to cough up more money.
-
Target Of Medicare Insider Trading Case Boasted He Was Unstoppable ‘Beast’
Prosecutors say hedge-fund traders made millions trading on information leaked from Medicare.
By Christina Jewett and Melissa Bailey -
Consumer Advocates Wary Of New Marketplace Rules For Brokers
Federal officials relaxed their rules this month about how brokers and insurers can work with individuals to apply for health law policies.
-
Molina Healthcare, A Top Obamacare Insurer, Investigates Breach Of Patients’ Data
“It’s unconscionable that such a basic, security 101 flaw could still exist at a major health care provider,” says one cybersecurity expert.
By Chad Terhune -
REPEAL & REPLACE WATCH
A Busy Week For Health: Budget Cuts, CBO Scores And Mitch McConnell’s Cryptic Signal
KHN’s Mary Agnes Carey and Julie Rovner discuss some of the developments that shook up health news this week.
-
Influx Of Elderly Patients Forces ER To Practice Comfort Care
Despite a culture clash and lack of time and training, ER doctors see how palliative care averts suffering for elderly patients with serious illnesses.
-
Putting A Lid On Waste: Needless Medical Tests Not Only Cost $200B — They Can Do Harm
The health care industry thrives on ordering up tests and treatments, but some hospitals are urging restraint.
By Chad Terhune -
REPEAL & REPLACE WATCH
GOP’s Health Bill Could Undercut Some Coverage In Job-Based Insurance
In states that take up the bill’s option to change the essential health benefits, the out-of-pocket spending limits and annual and lifetime caps on coverage in large group plans could fray.
-
New York State Wants Its Prescription Drug Money Back — Or Else
A new law gives Medicaid regulators power to threaten drugmakers with cost-effectiveness scrutiny unless they grant additional rebates.
-
California Bill Addresses Safety Concerns At Dialysis Clinics
Legislation would require minimum staffing levels, longer intervals between patients and more frequent state inspections.
By Anna Gorman -
UnitedHealth Doctored Medicare Records, Overbilled U.S. By $1 Billion, Feds Claim
The company, which is the nation’s largest Medicare Advantage operator, denies wrongdoing and argues that the Justice Department “fundamentally misunderstands” how Medicare Advantage works.
By Fred Schulte